Author： Chantry D.
Publisher： Informa Healthcare
ISSN： 1472-8214
Source： Expert Opinion on Emerging Drugs, Vol.4, Iss.1, 1999-01, pp. : 5-13
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Safety of Tumour Necrosis Factor- Antagonists
By Khanna D. McMahon M. Furst D.E.
Drug Safety, Vol. 27, Iss. 5, 2004-01 ,pp. :
Access to resources
Recommend
Tumour necrosis factor antagonists: Hodgkin's lymphoma: 3 case reports
Reactions Weekly, Vol. 1, Iss. 1215, 2008-01 ,pp. :
Tumour necrosis factor antagonists: Dermatitis (first report with lenalidomide): 5 case reports
Reactions Weekly, Vol. 1, Iss. 1100, 2006-01 ,pp. :